Navigation Links
BioDuro & The National Center for Safety Evaluation of Drugs Received Full AAALAC Accreditation
Date:4/18/2008

BEIJING, April 18 /PRNewswire/ -- BioDuro & The National Center for Safety Evaluation of Drugs (NCSED, the "Center") in Beijing announce their receipt of full AAALAC accreditation. BioDuro and the Center collaborate to offer preclinical toxicology and large animal DMPK for clients worldwide.

Dean Rodwell, BioDuro's Vice-President of Toxicology stated "Although we have been operating under this standard for over a year, it is exciting to receive this important, internationally recognized official accreditation. BioDuro is now working closely with the Center to attain US FDA GLP certification and expects to be operating at this level by the third quarter of 2008."

Dr. Li Bo from the National Institute for the Control of Pharmaceutical and Biological Product (NICPBP) mentioned "AAALAC accreditation is a wonderful step as we expand our exceptional services."

The Center's main tasks are to carry out the toxicological tests and preclinical safety evaluation of drugs in the field of non-clinical research and development. It possesses experienced scientific and technical teams in disciplines such as pharmacology, toxicology, laboratory animal services, analytical chemistry, biochemistry, physiology and pathology. It is well equipped with instrumentation and animal facilities and is strictly managed according to Chinese GLP. The Center is currently engaged in toxicological tests and preclinical safety evaluation of drugs, on the basis of drug registration requirements of both domestic and international regulations.

BioDuro is a US-based, fully-integrated, global life science outsourcing services company, committed to creating high-quality, integrated R&D capabilities in China to meet the growing needs of the global biotechnology and pharmaceutical industries. Our functional strengths are in medicinal chemistry, synthetic chemistry, biology, assay development/screening, DMPK and toxicology. We have hired exceptional, experienced people in each discipline from around the world. We have placed a premium on drug discovery experience in the West and have many scientists with such experience. We have built world-class laboratories for each function in Beijing and have unique access to toxicology and large animal DMPK via our collaboration with the Center. Our customers are over 40 pharmaceutical and biotechnology companies including 9 of the top 12 global pharmaceutical companies. Unlike many others, BioDuro's leadership team is built with true expertise across all aspects of drug discovery and a deep understanding of how to build and operate a high quality professional services organization.

For more information on the services offered by BioDuro and The National Center for Safety Evaluation of Drugs please contact BioDuro at 4350 La Jolla Village Drive, Suite 450, San Diego, CA 92121, 1-888-251-1697, info@bioduro.com or visit our website at http://www.bioduro.com.


'/>"/>
SOURCE BioDuro
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
4. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
5. The Government of Quebec and the New Canadian Government Invest in the Creation of an International Biobank
6. International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers
7. Arrow International Files and Mails Definitive Proxy Materials
8. Niceware International Announces Licensed Vendor Status with ICCBBA, Inc. to Provide ISBT 128-compliant Software
9. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
10. Viragen International to Reverse Split Its Common Stock
11. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , ... announced today the Clinical Reach Virtual Patient Encounter CONSULT module which enables ... the physician and clinical trial team. , Using the CONSULT module, patients and physicians ...
(Date:6/27/2016)... , ... June 27, 2016 , ... ... for Amgen, will join the faculty of the University of North Carolina ... professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the ...
(Date:6/27/2016)... --  Ginkgo Bioworks , a leading organism design ... awarded as one of the World Economic Forum,s ... innovative companies. Ginkgo Bioworks is engineering biology to ... in the nutrition, health and consumer goods sectors. ... including Fortune 500 companies to design microbes for ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
Breaking Biology Technology:
(Date:6/22/2016)... , June 22, 2016   ... management and verification solutions, has partnered with ... software solutions for Visitor Management, Self-Service Kiosks ... provides products that add functional enhancements to ... provides corporations and venues with an automated ...
(Date:6/21/2016)... VANCOUVER, British Columbia , June 21, 2016 ... been appointed to the new role of principal ... has been named the director of customer development. ... , NuData,s chief technical officer. The moves reflect ... development teams in response to high customer demand ...
(Date:6/16/2016)... 2016 The global ... reach USD 1.83 billion by 2024, according to ... Technological proliferation and increasing demand in commercial buildings, ... drive the market growth.      (Logo: ... development of advanced multimodal techniques for biometric authentication ...
Breaking Biology News(10 mins):